There are still considerable gaps in medication care, with Black enrollees having lower use than Whites
Improvement seen in treatment satisfaction and several secondary end points for depot buprenorphine versus sublingual buprenorphine
Differences between the two trajectories persist in opioid fills, misuse beyond 12 months
Concurrent tobacco use and minority race/ethnicity status further worsen outcomes with cannabis use disorder during pregnancy